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Abstract Hip fracture, a moderate musculoskeletal trauma,
is associated with a high postoperative mortality. Most
patients are elderly, with comorbid conditions and often
with heart disease. The objective of this study was to find
out if clinical parameters and analyses of specific muscle
enzymes could predict three month postoperative mortality.
A total of 302 patients above 75 years of age with hip
fracture were consecutively enrolled. Baseline information
on age, sex and comorbidity assessed with the American
Society of Anesthesiologists (ASA) score was obtained
before surgery. Creatine kinase (CK), myocardium-specific
creatine kinase (CK-MB) and troponin T (TnT) were
analysed from venous blood, collected the day before
surgery (−1) and postoperatively, within 24 hours (0) and
on days one (+1) and four (+4). The overall three month
mortality was 19.5%. Multivariate analyses showed that
age, male sex and comorbidity (ASA) correlated with
mortality (p=0.027, p=0.002, p<0.001, respectively).
Surgery induced a two- to threefold increase of CK and
CK-MB but without any correlation with mortality. How-
ever, high TnT levels >0.04 μg/l correlated significantly
with death (days −1, +1 and +4, p=0.003, p=0.005 and
p=0.003, respectively). Multivariate analyses, adjusted for
age, sex and ASA category, confirmed this correlation (day
+4, p=0.008). Thus, in elderly patients with comorbidities
undergoing hip fracture surgery information on sex, age,
ASA category and postoperative laboratory analyses on
TnT provide the clinicians with useful information on
patients at risk of fatal outcome.
Introduction
Hip fracture is a moderate musculoskeletal trauma that
mainly affects the older population with comorbid
conditions. The number will increase markedly in
coming years due to the ageing of the population [1].
Comorbidity and the double trauma may dispose them to
serious postoperative adverse outcomes and a high
mortality dominated by cardiovascular events [2–5].
Myocardial injury may be difficult to diagnose because
of impaired communication, limitations of clinical mani-
festation and non-specific electrocardiographic (ECG)
changes [6, 7]. The isoenzyme myocardium-specific
creatine kinase (CK-MB) is expressed in the myocardium
and CK in the skeletal muscle cells. These two enzymes
have traditionally been analysed in plasma to distinguish
myocardial injury and skeletal muscle injury [8, 9].
Troponins have been shown to be more specific and
sensitive to cardiac injury [10, 11]. Increased plasma
levels of troponin have also been reported in pulmonary
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and cardiac surgery. In those conditions high plasma
troponin levels have been associated with severe adverse
outcomes and increased mortality [7, 12–15].
In this study we wanted to test the hypothesis that fatal
outcome following hip fracture is not related to cardio-
muscular plasma enzymes.
Materials and methods
The study was approved by the Regional Ethics Committee
and National Medical Authorities and conducted in accor-
dance with the Helsinki declaration.
A total of 302 consecutive patients over 75 years of age
with dislocated hip fractures were enrolled in the study at
Elverum (ECH) and Buskerud (BCH) central hospitals
during the period 2005–2009. Comorbidity was routinely
assessed according to the classification of the American
Society of Anesthesiologists (ASA) [16]. All patients
received loco-regional analgesia. A hemiprosthesis was
inserted through a lateral incision and fixed with or without
bone cement (Landos Titan or Landos Corail, DePuy,
Warsaw, IN, USA).
Thromboprophylaxis (low molecular weight heparins)
was administered routinely preoperatively (on hospital
admission) with dalteparin 5000 IU s.c. (ECH) or enox-
aparin 40 mgs.c. (BCH) and subsequently once daily for
about one week.
Blood samples were obtained from an antecubital
vein, collected preoperatively (−1) and postoperatively
[within 24 hours (0)] and on days one [24–4 8h( + 1 ) ]
and four (+4). The blood samples were immediately
processed and analysed according to local laboratory
routines. Troponin T (TnT) and CK-MB were measured
by electrochemiluminescence immunoassay (ELICA,
Roche, Basel, Switzerland and Abbott, Abbott Park,
IL, USA). CK was measured by absorption photometry
(Roche, Basel, Switzerland and Abbott, Abbott Park, IL,
USA). Values for TnT were only measured at the ECH
study centre (n=146).
Descriptive statistics were mean and standard deviation
if not otherwise stated. Differences between mortality
groups were tested using a two-sample t test or chi-square
test for continuous or categorical data, respectively. Non-
parametric Mann-Whitney tests were done for TnT due to
skewed distribution. A linear mixed model for repeated
measurements with a random intercept and Bonferroni
adjusted pairwise post hoc comparisons were used to
analyse the biochemical markers with respect to mortality
and repeated venous blood analyses. Univariate and
stepwise multivariate logistic regression analyses were used
to estimate unadjusted and adjusted odds ratios with respect
to survival at the three month follow-up. Results from
multivariate logistic regression were based on models includ-
ing only significant terms from stepwise regression to
maximise the number of patients included. Missing data were
assumed to be completely at random. The significance level
was set to p<0.05.
Results
Demographic and clinical characteristics of patients are
shown in Table 1. There were 229 women and 72 men,
with a mean age of 84.7 (SD 5.1) and 83.7 (SD 4.7) years,
respectively. By three months, 59 of 302 (19.5%) had died,
62% women and 38% men.
ASA, male sex and age were significantly associated
with mortality within three months (Table 1).
Within one day after surgery, the plasma levels of CK
and CK-MB increased nearly threefold (inverse for the
ratio). On days −1 and +1, CK and CK-MB values were
significantly higher among those who died compared to
those who survived (p=0.001 and p=0.031, respectively)
(Fig. 1). On the fourth postoperative day, TnT plasma levels
rose twofold in the mortality group and remained un-
changed in the alive group. The plasma levels were
significantly higher (p<0.05) in the mortality group at all
sampling times except at day 0 (Fig. 1)
Table 1 Demographic and clinical characteristics of patients at 3-
month follow-up
Characteristics Alive
(n=243)
Dead
(n=59)
p values
Age, years (mean ± SD) 84.1 (5.1) 86.2 (4.6) 0.004
Sex
Female 193 (79.4%) 37 (62.7%) 0.005
Male 50 (20.6%) 22 (37.3%)
Mobility
Not mobile 37 (15.8%) 10 (17.2%) 0.109
Living aid 23 (9.8%) 5 (8.6%)
Crutches 51 (21.8%) 21 (36.2%)
No aid 123 (52.6%) 22 (37.9%)
ASA score
I 10 (4.2%) 0 (0.0%) <0.001
II 103 (42.9%) 9 (15.3%)
III 116 (48.3%) 38 (64.4%)
IV 11 (4.6%) 12 (20.3%)
ASA American Society of Anesthesiologists
Minor deviations between total number of patients in categories
compared to number alive or dead are due to missing data. Missing
data are assumed to be completely at random
904 International Orthopaedics (SICOT) (2011) 35:903–907The TnT plasma concentrations were split into three
equal-sized data subsets, i.e. ≤0.01, 0.01–0.04 and
>0.04 μg/l, and the ratios of CK-MB to CK concentrations
were split into two equal-sized data subsets, i.e. below and
above 0.02. They were analysed for mortality association.
Univariate logistic regression analyses showed that plasma
concentrations above 0.04 μg/l before surgery correlated
with three month mortality [odds ratio (OR) 10.9, 95%
confidence interval (CI) 2.2–54.0, p=0.003] (Table 2).
Stepwise multivariate logistic regression with age, sex,
ASA category, levels of TnT and ratio of CK-MB to CK
concentrations were performed. High TnT plasma concen-
tration was associated with increased mortality (OR 6.1
95% CI 6–23.1, p=0.008) at day four after surgery. No
statistically significant association was found for the ratio
of CK-MB to CK during the entire sampling period when
adjusted for age, sex and ASA (Table 3). Similar regression
analyses were done for CK and CK-MB. On day +1, the
CK-MB was associated with mortality (OR 1.1, 95% CI
1.02–1.2, p=0.012). We found that our hypothesis, stating
no predictive value from cardio-muscular plasma enzymes
with regard to early mortality in patients with hip fracture,
was false.
Discussion
This prospective study on 302 elderly patients with hip
fracture disclosed that 19.5% had died within three months.
Preoperatively obtained basic patient information was
shown to be of particular importance to assess the risk of
postoperative mortality. ASA score on comorbidity, male
sex and age correlated significantly with three month
mortality, also described by other investigators [17–19].
Autopsy studies have shown that cardiovascular events
are the main cause of death after hip fracture surgery [20,
21]. Autopsies are rarely done today and the direct cause of
postoperative death has not been possible to establish in
this or in other recently conducted studies.
In the elderly perioperative myocardial ischaemia is
often clinically silent, without haemodynamic or notable
ECG changes [22–25]. Over the years, biochemical plasma
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Fig. 1 Mean and 95% confidence intervals for troponin T, creatine
kinase (CK), myocardium-specific creatine kinase (CK-MB) and ratio
of CK-MB to CK before surgery, perioperatively and 1 and 4 days
after surgery for 3-month mortality. Statistical significance (p<0.05)
between mortality groups is indicated by an asterisk. Statistically
significant (p<0.05) differences between before surgery and during
follow-up are indicated by the connecting lines. Day −11 day before
surgery, day 0 within 24 h after the operation, day +1 24–48 h
postoperatively, day +4 4 days after surgery
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from skeletal muscle damage, an approach also adopted
in this study. CK, reflecting the general skeletal muscle
trauma, increased perioperatively. This finding is in line
with a recent study in elective hip replacement surgery
[26]. Potential heart muscle damage was investigated in
this study with CK-MB and TnT analyses. We found
small and inconsistent differences for CK and CK-MB
plasma levels between those who died and those who
survived. The ratio of CK-MB to CK was decreased from
hospital admission (day −1) to day 0 and stabilised,
indicating that skeletal muscle damage dominated and
that any myocardial injury remained undetected. Logistic
regression analyses showed no correlation with postop-
erative mortality. This analysis suggests that CK and CK-
MB are unspecific enzymes that are not distinct for
skeletal and cardiac muscle damage following a hip
fracture and are not feasible as prognostic markers of
mortality, a finding consistent with other investigators
[27].
Release of troponins into the circulation is considered to
specifically reflect cardiac injury [28]. In our study we
analysed TnT and found that the plasma concentration was
significantly higher on the fourth postoperative day in
patients that subsequently died compared to those who were
alive. Patients with TnT levels above 0.04 μg/l had a six
times higher risk of dying vs those with normal plasma
levels. This calculation was robust when correction was
done for age, sex and comorbidity (ASA score). These
results fit with other reports that showed a second wave of
troponin elevation several days after surgery which corre-
lated with postoperative mortality [13, 29].
In summary, this study showed that basic clinical
information on sex, age and comorbidity (ASA score) and
a high postoperative plasma concentration of TnT
>0.04 μg/l are robust predictors of three month postoper-
ative mortality in the elderly undergoing hip fracture
surgery. This information may be of importance for
therapeutic and post-hospital health care intervention.
Table 3 Results from multivariate stepwise logistic regression models predicting 3-month mortality (death)
Variables Day −1 Day 0 Day +1 Day +4
Adjusted OR
(95% CI)
p values Adjusted OR
(95% CI)
p values Adjusted OR
(95% CI)
p values Adjusted OR
(95% CI)
p values
Age 1.1 (1.0–1.2) 0.006 1.1 (1.0–1.2) 0.006 1.1 (1.0–1.2) 0.001 1.1 (1.0–1.2) 0.027
If male 2.4 (1.2–4.6) 0.013 2.4 (1.2–4.6 0.013 2.7 (1.4–5.1) 0.002 –
ASA 3.3 (2.0–5.6) <0.001 3.3 (2.0–5.6) <0.001 ––
CK-MB/CK ––––
TnT
≤ 0.01 –––1.0 (reference) –
0.01–0.04 –––1.9 (0.4–9.4) 0.450
>0.04 –––6.1 (1.6–23.1) 0.008
OR odds ratio, CI confidence interval, ASA American Society of Anesthesiologists, CK-MB/CK ratio of myocardium-specific creatine kinase to
creatine kinase, day −1 1 day before surgery, day 0 within 24 h after surgery, day +124–48 h postoperatively, day +4 4 days after surgery
Table 2 Results from univariate logistic regression models predicting
3-month mortality (death)
Variables Unadjusted OR (95% CI) p values
Age 1.1 (1.0–1.1) 0.004
If male 2.4 (1.3–4.4) 0.006
ASA 3.7 (2.2–6.1) <0.001
If CK-MB/CK > 0.02
Day −1 1.6 (0.8–3.4) 0.225
Day 0 0.7 (0.3–1.6) 0.413
Day +1 1.5 (0.8–2.9) 0.239
Day +4 1.2 (0.6–2.4) 0.620
TnT
Day −1 ≤0.01 1.0 (reference)
0.01–0.04 1.5 (0.4–6.0) 0.532
>0.04 11.0 (2.2–54.6) 0.003
≤0.01 1.0 (reference)
Day 0 0.01–0.04 1.5 (0.4–5.4) 0.556
>0.04 2.9 (0.7–11.0) 0.127
≤0.01 1.0 (reference)
Day +1 0.01–0.04 1.6 (0.4–7.4) 0.512
>0.04 6.0 (1.7–21.1) 0.005
≤0.01 1.0 (reference)
Day +4 0.01–0.04 3.3 (0.7–15.0) 0.126
>0.04 7.0 (1.9–25.6) 0.003
OR odds ratio, CI confidence interval, ASA American Society of
Anesthesiologists, CK-MB/CK ratio of myocardium-specific creatine
kinase to creatine kinase, day −1 1 day before surgery, day 0 within
24 h after surgery, day +124–48 h postoperatively, day +4 4 days
after surgery
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